Insider Selling: Puma Biotechnology, Inc. (NASDAQ:PBYI) CEO Sells $61,753.95 in Stock
Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Free Report) CEO Alan H. Auerbach sold 18,885 shares of Puma Biotechnology stock in a transaction that occurred on Tuesday, July 2nd. The stock was sold at an average price of $3.27, for a total value of $61,753.95. Following the completion of the transaction, the chief executive officer now […]
More Stories
Curtiss-Wright Co. (NYSE:CW) CFO Buys $11,863.62 in Stock
Curtiss-Wright Co. (NYSE:CW – Get Free Report) CFO K Christopher Farkas purchased 51 shares of the firm’s stock in a...
MongoDB, Inc. (NASDAQ:MDB) CFO Michael Lawrence Gordon Sells 1,569 Shares
MongoDB, Inc. (NASDAQ:MDB – Get Free Report) CFO Michael Lawrence Gordon sold 1,569 shares of MongoDB stock in a transaction...
Insider Buying: Associated Capital Group, Inc. (NYSE:AC) Major Shareholder Buys $21,145.00 in Stock
Associated Capital Group, Inc. (NYSE:AC – Get Free Report) major shareholder Mario J. Gabelli acquired 500 shares of the company’s...
The Mosaic Company (NYSE:MOS) Receives $38.29 Consensus Price Target from Brokerages
The Mosaic Company (NYSE:MOS – Get Free Report) has received a consensus recommendation of “Hold” from the thirteen analysts that...
Analyzing The Baldwin Insurance Group (BWIN) and Its Rivals
The Baldwin Insurance Group (NASDAQ:BWIN – Get Free Report) is one of 39 publicly-traded companies in the “Insurance agents, brokers,...
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from...